INSIGHTS ON QUALITY CONTROL
-
![Webinar Gowning_1200x627_ondemand Ilaria Manni]( "Practical Considerations For Aseptic Gowning In Contamination Control Strategies")
Practical Considerations For Aseptic Gowning In Contamination Control StrategiesMaster the complexities of aseptic gowning and Annex 1 compliance. Explore risk-based strategies to mitigate human-source contamination and strengthen your facility's sterility assurance.
-
![CMO Validation as a Service]( "CMO Validation As A Service")
CMO Validation As A ServiceLearn about the highly successful commissioning and qualification of Wheeler's Oklahoma City CDMO facility with the overarching goal of ensuring all equipment was qualified for a Phase 3 clinical production campaign.
-
![Syringe vaccine]( "Understanding cGMPs For Phase 1 Investigational Drugs")
Understanding cGMPs For Phase 1 Investigational DrugsLearn how a structured, risk-based approach to early-phase manufacturing can help streamline processes, reduce costs, and accelerate the path to first-in-human trials while meeting FDA cGMP guidelines.
-
![3P innovation - achieving licensing]( "Achieving Licensing For A Healthcare Solution")
Achieving Licensing For A Healthcare SolutionFacing strict regulations and tricky powders, a healthcare client sought an advanced filling solution. Learn how an expert collaboration led to licensed product, boosting precision and productivity.
-
The Hidden Costs Of Paper Logbooks3/19/2026
Stop losing time and capacity to manual paperwork. Learn how digital workflows eliminate compliance risks and unlock the actionable data needed to optimize life sciences manufacturing.
-
Inside The Cleanroom: Building A Culture Of Clean Beyond The CCS Blueprint2/12/2026
Achieving sterile excellence requires more than just rigid protocols. Learn how to foster a proactive mindset across your entire organization to ensure long-term facility integrity.
-
Designing An Environmental Monitoring Solution For GMP Applications3/5/2026
Implement robust contamination control strategies that align with current regulatory requirements. Optimize your environmental monitoring framework through precise design and data-driven analysis.
-
Host Cell Impurities, Bioassays, Micro-Flow Imaging4/9/2024
Ensuring the safety and efficacy of cutting-edge biopharmaceuticals hinges on meticulous quality control measures. Explore the role of qPCR and MFI in safeguarding drugs from potential contamination.
-
Software Simplifies 21 CFR Part 11 and Annex 11 Compliance12/9/2024
21 CFR Part 11 and Annex 11 regulate electronic records and signatures in biomanufacturing, ensuring data integrity, security, and compliance while enabling efficient processes and regulatory alignment.
QUALITY CONTROL SOLUTIONS
-
![vials]( "Container Closure Integrity Of Parenteral Products")
The United States Pharmacopeia USP 1207 guidance has been revised, encouraging the preference to deterministic, quantitative, and reliable non-destructive technologies to comply with quality standards.
-
![Data Accuracy GettyImages-953027306]( "Detection Of Endotoxin And Non-Endotoxin Pyrogens By MAT")
Performing endotoxin testing? Trust your data with a Monocyte Activation Test that mimics the human immune reaction and detects both endotoxins and non-endotoxin pyrogens.
-
![GettyImages-2187764040-cell-culture-testing-manufacturing-in-lab]( "Laboratory Services")
Integrated lab services deliver method development, validation, and testing across modalities, supporting quality, compliance, and formulation progress from early development to commercialization.
-
![Blister Package]( "Seal Inspection Technologies for Tablets & Capsules Packaging")
Non-destructive package testing of multi-cavity blisters – completely tool-less for different blister formats.
-
![Parenteral-Drug-Vials]( "Container Closure Integrity Testing Systems For Vaccines")
The pharmaceutical industry continues to bring breakthroughs in the field of new vaccines and drug delivery systems amidst the increased scrutiny of the regulators. The packaging acts as the primary sterile barrier in drug delivery systems that safeguard the drug product through its life cycle. The efficiency of the primary sterile barrier and the functional components are of utmost importance to patient safety.
